Chinese patient is first to be treated with CRISPR-edited cells

illustration of scissors cutting DNA

Researchers used molecular scissors called CRISPR/Cas9 to engineer immune cells that were then injected into a patient with lung cancer, Nature reports.

WILDPIXEL/ISTOCKPHOTO

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content